 |
PDBsum entry 4imk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4imk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Plos One
8:e61953
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domain.
|
|
S.Fenn,
C.B.Schiller,
J.J.Griese,
H.Duerr,
S.Imhof-Jung,
C.Gassner,
J.Moelleken,
J.T.Regula,
W.Schaefer,
M.Thomas,
C.Klein,
K.P.Hopfner,
H.Kettenberger.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bispecific antibodies are considered as a promising class of future
biotherapeutic molecules. They comprise binding specificities for two different
antigens, which may provide additive or synergistic modes of action. There is a
wide variety of design alternatives for such bispecific antibodies, including
the "CrossMab" format. CrossMabs contain a domain crossover in one of
the antigen-binding (Fab) parts, together with the "knobs-and-holes"
approach, to enforce the correct assembly of four different polypeptide chains
into an IgG-like bispecific antibody. We determined the crystal structure of a
hAng-2-binding Fab in its crossed and uncrossed form and show that CH1-CL-domain
crossover does not induce significant perturbations of the structure and has no
detectable influence on target binding.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|